ClinicalTrials.gg
Enrolling by invitationNCT06104397Updated May 28, 2026

Exercise Strategies in Parkinson's Disease

An interventional study of Written exercise guidance by neurologist and Physical therapy in Parkinson Disease, sponsored by Shirley Ryan AbilityLab. Enrolling by invitation at 7 sites in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-05-28.

Sponsored by Shirley Ryan AbilityLab · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
288
Allocation
Non-randomized
Ages
18 Years to 89 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 1,649 studies in Parkinson Disease with a site in United States — 304 open to participants now, 387 under way, 7 of them phase 3. Parkinson Disease · United States.

Planned enrollment
117th of 1,256
288 · median 36
Started
2024
with 80 others
No phase
585 of 1,649
146 open now
Primary completion
2028-05
later than 270 of 384 live
Registered
1,399th of 1,649
by date

Among the 1,649 studies in Parkinson Disease with a site in United States, this one is the 117th largest by planned enrollment of the 1,256 interventional ones that give a count, is one of 81 that started in 2024, is one of 585 with no phase, reaches primary completion later than 270 of the 384 other live ones, and was the 1,399th registered.

Parkinson Disease

4,573 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

304 of the 1,649 studies in Parkinson Disease with a site in United States are open now. Recruiting first, the newest first:

299 more — sign in →

All 304 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 748 Parkinson Disease studies recruiting now, 311 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 63 take children under 18; 189 take healthy volunteers.

This study: 18 Years to 89 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,649 studies in Parkinson Disease with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn about exercise and physical activity people with Parkinson's Disease. The main questions it aims to answer are: 1) learn about the physical activity and exercise behaviors of people with Parkinson's Disease over the course of a year and 2) compare 3 exercise guidance strategies aimed to impact exercise behavior: standard care, written exercise guidance from neurologist and/or physical therapy.

During the course of the study:

  1. Participants will use activity trackers and a mobile phone application to monitor their exercise participation.
  2. At the same time, the research team will be working with the participant's medical teams at Northwestern Medicine and University of Chicago Medical Center to improve the way that they deliver exercise guidance using verbal instructions and encouragement, written exercise guidance, and/or physical therapy.
Read the detailed description

The purpose of this study is to gain a better understanding of how people with Parkinson's disease (PD) manage their physical activity and exercise participation with different levels of support from their communities and clinicians. We will evaluate exercise and physical activity every 3 months in a cohort of people with PD from two medical centers in the Chicagoland area: Northwestern Medicine and University of Chicago Medical Center.

During this study, we will evaluate differences in 12-month physical activity trajectories between groups enrolled during each of three conditions: (1A) standard care (condition 1, year 1), (1B) written exercise guidance (condition 2, year 2), and (1C) Consultative PT (condition 3, year 3). People with PD will be enrolled each year into an activity and exercise tracking study. Participants will be tracked using a remote therapeutic monitoring platform (Datos) and commercial grade activity trackers. Research-grade actigraphy and patient reported outcome measures will be monitored every 3 months for the first year.

All participants will be enrolled in an exercise and physical activity tracking study where they can use a remote therapeutic monitoring platform (Datos Health) to share their exercise and physical activity data with their medical and rehabilitation teams at NM and UCMC. The platform allows for synchronization of patients' activity data from their fitness tracker or smartwatch to the secure cloud-based platform. The platform can summarize steps per day, activity intensity, minutes of moderate-vigorous physical activity per day based on target heart rate zones (including an ability for physical therapists to customize the target heart rate zone).

At the 2 sites of care (Northwestern Medicine and University of Chicago), participants will be recruited based on contacting consecutive patients who meet the inclusion criteria based on scheduling and EMR screening prior to their visit with their neurologists. Contacting consecutive patients will ensure greater potential equity of enrolling participants rather than only patients engaged in support groups and exercise classes. However, after 3 months of recruitment, we will conduct a preliminary analysis of the numbers, recruitment rates, and characteristics (age, sex, race, ethnicity, disease duration, education) of the enrolling participants compared to the demographics of each clinic as a whole. We will then determine if we should use targeted recruitment strategies to increase reach to specific groups or recruitment rates by doing one or more of the following: (1) sending measures through MyChart to potentially eligible patients targeting or oversampling for higher socioeconomic, race, or ethnicity diversity or (2) reaching out to local community exercise classes or support groups using emails to community advocates and flyers to increase sample size more rapidly.

Consecutive patients meeting the eligibility criteria will be approached by a site study team member. The first contact may occur before or during a medical (physician, physician assistant, nurse practitioner) visit. The electronic health record system will be used to screen participants for eligibility in the few weeks before their visit through an institutional review board-approved electronic data warehouse data waiver. Attempts will be made to contact potential participants before their appointments, with a research coordinator attempting contact at their visit if there is no response to early contacts. If time is limited during the patient's session, we will use patient portal communication and/or phone calls after their visits depending on the preferences of each site (which will be determined during the pre-implementation barrier assessment).

Screening for eligibility will occur via a combination of data available in the EMR for existing patients and a quick screening questionnaire that can be done in person or over the phone. After identifying that the participant is interested and satisfies the inclusion criteria for the study, they will be sent an e-consent. Once consent is obtained, they will work with the study team to set a time for the baseline assessment period which will include ensuring the participant has their own -wrist-worn activity tracker and is able to get commercial grade activity tracker from the research team. At baseline and every 3-months throughout the 12-month (baseline, 3-months, 6-months, 9-months, 12-months) study, participants will complete online survey assessments including demographic questionnaires, habits and perceptions of physical activity and exercise, and healthcare and exercise resource utilization. Participants will, also, wear a research-grade physical activity monitor on a belt clip around their waist for 7-consecutive days at baseline, 3-, 6-, 9-, 12-months. In addition to research-grade physical activity monitoring, participants will be asked to asked to a personal commercially available activity tracker daily which will be synced to the Datos Health app.

03

Conditions studied

  • Parkinson Disease

Keywords

  • Exercise
  • Physical Activity
  • Physical Therapy
  • Activity Monitoring
04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Have a neurologist confirmed diagnosis of Parkinson's Disease
  • Hoehn\&Yahr Stage 1-3
  • Age 18-89 years old
  • Ambulatory
  • Written and verbal basic English proficiency adequate for survey completion
  • Have a smart phone
  • Willing to sync activity tracker with Datos health app at least every 3 days
  • Willing to accept Datos' Terms and Conditions

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of dementia or mild cognitive impairment in medical record
  • Uses a rollator or rolling walker for mobility
  • Other comorbidities significantly limiting ability to participate in exercise >12 weeks
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
288 participants (estimated)

Study arms

  • No intervention
    Standard Care

    Standard care patient's with Parkinson's Disease are receiving at each site.

  • Active comparator
    Written exercise guidance by neurologist

    Neurologists will provide written exercise education and guidance to their patients with Parkinson's Disease.

    Other: Written exercise guidance by neurologist

  • Experimental
    Physical therapy

    A consultative model of physical therapy will be implemented at each site for patient's with Parkinson's Disease.

    Other: Physical therapy

Interventions

  • OtherWritten exercise guidance by neurologist

    Neurologists will provide written exercise education and guidance to their patients with Parkinson's Disease during neurologist visits and/or in after visit summary in the patient's EMR patient portal. The research team will facilitate the development of the written exercise guidance with input and feedback from each site's neurology, clinical, and administrative teams.

  • OtherPhysical therapy

    A consultative model of physical therapy - a lower dose of physical therapy focused on physical activity and exercise promotion and coaching - will be implemented into each site. In the consultative model of physical therapy, visits are scheduled around needs of the patient, however will involve 1-4 additional visits within 3 months of evaluation and is based on personal factors that influence their exercise prognosis such as self-efficacy, readiness to change, fitness level, age, health literacy, comorbidities, and Parkinson's Disease-related motor and non-motor impairments.

06

What researchers measure

Primary outcomes

  1. Accelerometer Measures

    Minutes per day of moderate to vigorous physical activity (MVPA)

    Time frame: Average 1-week MVPA measured every 3-months throughout 12-month study period

Secondary outcomes

  1. Steps per Day

    Steps per day

    Time frame: Average 1-week step counts measured every 3-months throughout 12-month study period

07

Study locations

7 sites
08

References and documents

Publications

  • Osborne JA, Botkin R, Colon-Semenza C, DeAngelis TR, Gallardo OG, Kosakowski H, Martello J, Pradhan S, Rafferty M, Readinger JL, Whitt AL, Ellis TD. Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From the American Physical Therapy Association. Phys Ther. 2022 Apr 1;102(4):pzab302. doi: 10.1093/ptj/pzab302. PubMed 34963139 ↗
  • Rafferty MR, MacDonald J, Byskosh A, Sloan L, Toledo S, Marciniak C, Simuni T. Using Implementation Frameworks to Provide Proactive Physical Therapy for People With Parkinson Disease: Case Report. Phys Ther. 2019 Dec 16;99(12):1644-1655. doi: 10.1093/ptj/pzz129. PubMed 31508801 ↗
  • Cavanaugh JT, Ellis TD, Earhart GM, Ford MP, Foreman KB, Dibble LE. Capturing ambulatory activity decline in Parkinson's disease. J Neurol Phys Ther. 2012 Jun;36(2):51-7. doi: 10.1097/NPT.0b013e318254ba7a. PubMed 22592060 ↗

Individual participant data

Plan to share: Yes — In accordance with the "NICHD Plans for Sharing Human and Non-Human Data and/or Biospecimens" policy, resulting data will be shared in the Data and Specimen Hub (DASH) in de-identified format. Our research results will also be made available to the public via summaries on the Shirley Ryan AbilityLab (SRAlab) website and Northwestern University's DigitalHub, a repository for scholarly output through Northwestern University developed by Galter Health Sciences Library (Northwestern).

Supporting information: Statistical analysis plan

Time frame: Data will become available following completion and analysis of research study data. Data will be stored in our laboratory data repository system and thus will be available indefinitely.

Access criteria: Data summaries will be publicly available on the Shirley Ryan AbilityLab website and Northwestern University DigitalHub. De-identified data will, also, be shared in the Data and Specimen Hub (DASH) through the NICHD.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for May 2028, 50 months after the start.

Of 1,291 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 50 months is above that.

Counting every sponsor, half of 1,367 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 23, 2023
First posted
Oct 27, 2023
StartActual
Mar 1, 2024
Primary completionEst.
May 31, 2028
CompletionEst.
May 31, 2028
Last update
May 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06104397
Responsible party
Miriam Rafferty (Director of Implementation Science, Shirley Ryan AbilityLab) — Principal investigator
First posted
Oct 27, 2023
Start date
Mar 1, 2024
Primary completion
May 31, 2028 (estimated)
Completion
May 31, 2028 (estimated)
Last update
May 28, 2026

Study contacts

Miriam Rafferty, PT, DPT, PhD
principal investigator · Shirley Ryan AbilityLab

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion